These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31381548)

  • 21. [Interventions for smoking cessation in 2018].
    Abdul-Kader J; Airagnes G; D'almeida S; Limosin F; Le Faou AL
    Rev Pneumol Clin; 2018 Jun; 74(3):160-169. PubMed ID: 29650283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tobacco smoking, nicotine, and nicotine and non-nicotine replacement therapies.
    Frishman WH; Ky T; Ismail A
    Heart Dis; 2001; 3(6):365-77. PubMed ID: 11975821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcome of smoking-cessation trial of nicotine chewing gum evaluated by analysis of nicotine in hair.
    Mizuno A; Uematsu T; Ishikawa T; Yoshimine N; Nakashima M
    Ther Drug Monit; 1997 Aug; 19(4):407-12. PubMed ID: 9263381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacotherapy of smoking cessation with application of nicotine and nicotine free drugs].
    Florek E; Piekoszewski W
    Przegl Lek; 2008; 65(10):700-5. PubMed ID: 19189582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Modern medical support for smoking cessation].
    Hering T
    Internist (Berl); 2009 Jan; 50(1):95-100. PubMed ID: 18946639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic review and meta-analysis of combination therapy for smoking cessation.
    Shah SD; Wilken LA; Winkler SR; Lin SJ
    J Am Pharm Assoc (2003); 2008; 48(5):659-65. PubMed ID: 18826906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developments in pharmacotherapy for tobacco dependence: past, present and future.
    Foulds J; Steinberg MB; Williams JM; Ziedonis DM
    Drug Alcohol Rev; 2006 Jan; 25(1):59-71. PubMed ID: 16492578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. National Trends in Smoking Cessation Medication Prescriptions for Smokers With Chronic Obstructive Pulmonary Disease in the United States, 2007-2012.
    Kwak MJ; Kim J; Bhise V; Chung TH; Petitto GS
    J Prev Med Public Health; 2018 Sep; 51(5):257-262. PubMed ID: 30286598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tobacco cessation pharmacotherapy use among First Nations persons residing within British Columbia.
    Wardman AE; Khan N
    Nicotine Tob Res; 2004 Aug; 6(4):689-92. PubMed ID: 15370165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Smoking, nicotine dependence and detoxification therapies].
    Finnish Association of General Practitioner's task force
    Duodecim; 2002; 118(24):2578-87. PubMed ID: 12572294
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacogenetic study of seven polymorphisms in three nicotinic acetylcholine receptor subunits in smoking-cessation therapies.
    Pintarelli G; Galvan A; Pozzi P; Noci S; Pasetti G; Sala F; Pastorino U; Boffi R; Colombo F
    Sci Rep; 2017 Dec; 7(1):16730. PubMed ID: 29196725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of advertising on nicotine replacement therapy demand.
    Tauras JA; Chaloupka FJ; Emery S
    Soc Sci Med; 2005 May; 60(10):2351-8. PubMed ID: 15748682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of iontophoresis in the administration of nicotine and new non-nicotine drugs through the skin for smoking cessation.
    Escobar-Chávez JJ; Merino V; López-Cervantes M; Rodríguez-Cruz IM; Quintanar-Guerrero D; Ganem-Quintanar A
    Curr Drug Discov Technol; 2009 Sep; 6(3):171-85. PubMed ID: 19496753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New medications for nicotine dependence treatment.
    Hurt RD
    Nicotine Tob Res; 1999; 1 Suppl 2():S175-9; discussion S207-10. PubMed ID: 11768177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. National trends in the provision of smoking cessation aids within the Veterans Health Administration.
    Jonk YC; Sherman SE; Fu SS; Hamlett-Berry KW; Geraci MC; Joseph AM
    Am J Manag Care; 2005 Feb; 11(2):77-85. PubMed ID: 15726855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden.
    Bolin K; Lindgren B; Willers S
    Chest; 2006 Mar; 129(3):651-60. PubMed ID: 16537864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antidepressive drug against nicotine. A method for smoking cessation].
    Haustein KO
    MMW Fortschr Med; 2000 Dec; 142(51-52):44-6. PubMed ID: 11194275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Status and costs of smoking cessation in countries of the Eastern Mediterranean Region.
    Heydari G; Talischi F; Mojgani N; Masjedi MR; Algouhmani H; Lando HA; Ahmady EA
    East Mediterr Health J; 2012 Nov; 18(11):1102-6. PubMed ID: 23301371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of CYP2B6 pharmacogenomics in bupropion-mediated smoking cessation.
    Tran AX; Ho TT; Varghese Gupta S
    J Clin Pharm Ther; 2019 Apr; 44(2):174-179. PubMed ID: 30578565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The prevalence of strategies for cessation of tobacco use in primary health care: an integrative review].
    Santos MDV; Santos SV; Caccia-Bava MDCGG
    Cien Saude Colet; 2019 Feb; 24(2):563-572. PubMed ID: 30726388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.